Principal Investigator
Sara Wester
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20231351
Clinical Trial Summary
A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to Determine the Efficacy and Safety of LASN01 in Patients with Thyroid Eye Disease
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Other